Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 28, 2012; 18(48): 7327-7332
Published online Dec 28, 2012. doi: 10.3748/wjg.v18.i48.7327
Published online Dec 28, 2012. doi: 10.3748/wjg.v18.i48.7327
Characteristics | Patients | P value | ||||
Group 1 (RLV < 35%) | Group 2 (40% > RLV > 35%) | Group 3 (RLV > 40%) | P1 | P2 | P3 | |
n = 14 | n = 20 | n = 117 | ||||
Demographic and intraoperative data | ||||||
Gender (M/F), 90/61 | 10/4 | 12/8 | 62/46 | 0.717 | 1.000 | 0.395 |
Age (yr) | 37.1 ± 8.7 | 41.0 ± 12.7 | 38.0 ± 9.8 | 0.337 | 0.156 | 0.431 |
Weight (kg) | 64.3 ± 11.4 | 61.7 ± 8.4 | 63.6 ± 11.8 | 0.463 | 0.500 | 0.844 |
Height (cm) | 164.9 ± 12.3 | 163.3 ± 9.1 | 164.5 ± 13.1 | 0.664 | 0.679 | 0.925 |
Operation time (min) | 389.9 ± 87.2 | 373.4 ± 60.5 | 363.7 ± 71.9 | 0.581 | 0.472 | 0.765 |
EBL (mL) | 602.8 ± 73.1 | 582.9 ± 81.6 | 531.3 ± 50.7 | 0.740 | 0.583 | 0.341 |
Preoperative laboratory data | ||||||
ALT (IU/L) | 28.2 ± 16.6 | 29.8 ± 15.7 | 27.8 ± 20.9 | 0.784 | 0.683 | 0.937 |
AST (IU/L) | 28.9 ± 17.4 | 25.6 ± 9.9 | 23.3 ± 11.1 | 0.496 | 0.389 | 0.105 |
TBIL (mg/dL) | 12.7 ± 3.8 | 13.9 ± 6.1 | 15.2 ± 7.0 | 0.529 | 0.413 | 0.189 |
Hemoglobin (g/L) | 147.1 ± 13.2 | 142.4 ± 17.2 | 141.5 ± 16.9 | 0.392 | 0.822 | 0.229 |
Volumetric data of Chengdu standard liver volume formula (mL) | ||||||
Whole liver volume of formula | 1072.88 ± 131.06 | 1043.84 ± 97.11 | 1065.33 ± 136.02 | 0.463 | 0.500 | |
Graft volume | 745.00 ± 100.22 | 653.80 ± 56.55 | 534.83 ± 89.26 | 0.006 | 0.000 | |
Remnant liver volume of formula | 327.88 ± 61.83 | 390.04 ± 48.46 | 530.50 ± 125.83 | 0.002 | 0.000 | |
Remnant volume/whole volume of Chengdu formula(%) | 30.56 ± 4.17 | 37.31 ± 2.06 | 49.63 ± 7.33 | 0.000 | 0.000 |
Grades, n (%) | Complications | n |
Grade 1, 28 (18.5) | Transient bile leak treated conservatively | 7 |
Superficial wound infection treated without antibiotics | 2 | |
Postoperative voice change | 3 | |
Mild pleural effusion treated conservatively | 2 | |
Mild subphrenic effusion treated conservatively | 5 | |
Hyperbilirubinemia > 1.3 mg/dL 7 d after operation | 9 | |
Grade 2, 9 (6.0) | Intra-abdominal bleeding requiring blood transfusion | 1 |
Bile leak not requiring ERCP or surgical intervention | 3 | |
Dyspepsia | 1 | |
Chyle leak | 1 | |
Wound infection requiring antibiotics | 1 | |
Pneumonia requiring antibiotics | 2 | |
Grade 3a, 8 (5.3) | Bile leak needing ERCP | 3 |
Pleural effusion requiring thoracic cavity puncture | 2 | |
Pleural effusion requiring thoracic drainage | 1 | |
Subphrenic infection requiring abdominal cavity puncture | 1 | |
Chylothorax requiring thoracic cavity puncture | 1 | |
Grade 3b, 5 (3.3) | Portal vein thrombosis requiring re-laparotomy | 1 |
Biliary stricture requiring ERCP with stent placement | 2 | |
Abdominal hematoma requiring intervention | 1 | |
Intra-abdominal bleeding requiring re-laparotomy | 1 | |
Grade 4a | 0 | |
Grade 4b | 0 | |
Grade 5 | 0 |
Complications | Grades | P value | ||||
No complications (n = 101) | Grade 1 (n = 28) | Grade 2 (n = 9) | Grade 3a (n = 8) | Grade 3b (n = 5) | ||
Group 1 (RLV < 35%), n = 14 | 3 | 5 | 3 | 2 | 1 | 0.000 |
Group 2 (40% > RLV > 35%), n = 20 | 10 | 4 | 3 | 1 | ||
Group 3 (RLV > 40%), n = 117 | 88 | 19 | 3 | 5 | 2 |
- Citation: Shi ZR, Yan LN, Du CY. Donor safety and remnant liver volume in living donor liver transplantation. World J Gastroenterol 2012; 18(48): 7327-7332
- URL: https://www.wjgnet.com/1007-9327/full/v18/i48/7327.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i48.7327